In this study, mTOR suppression by siRNA or miR-199a-3p potentiates cisplatin sensitivity of CCA cell lines indicating mTOR pathway regulates cisplatin activity in CCA although the exact mechanism is unclear [88]. Here, MTOR is linked to cholangiocarcinoma.